Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Integrating cryptococcal antigen screening and pre-emptive treatment into routine HIV care.

Rajasingham R, Meya DB, Boulware DR.

J Acquir Immune Defic Syndr. 2012 Apr 15;59(5):e85-91. doi: 10.1097/QAI.0b013e31824c837e. Review.

2.

Universal screening of Tanzanian HIV-infected adult inpatients with the serum cryptococcal antigen to improve diagnosis and reduce mortality: an operational study.

Wajanga BM, Kalluvya S, Downs JA, Johnson WD, Fitzgerald DW, Peck RN.

J Int AIDS Soc. 2011 Oct 11;14:48. doi: 10.1186/1758-2652-14-48.

3.

Cost-effectiveness of CRAG-LFA screening for cryptococcal meningitis among people living with HIV in Uganda.

Ramachandran A, Manabe Y, Rajasingham R, Shah M.

BMC Infect Dis. 2017 Mar 23;17(1):225. doi: 10.1186/s12879-017-2325-9.

4.

Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa.

Jarvis JN, Harrison TS, Lawn SD, Meintjes G, Wood R, Cleary S.

PLoS One. 2013 Jul 19;8(7):e69288. doi: 10.1371/journal.pone.0069288. Print 2013.

5.

Preventing deaths from cryptococcal meningitis: from bench to bedside.

Roy M, Chiller T.

Expert Rev Anti Infect Ther. 2011 Sep;9(9):715-7. doi: 10.1586/eri.11.86. Review.

PMID:
21905781
6.

Cryptococcal antigen prevalence in HIV-infected Tanzanians: a cross-sectional study and evaluation of a point-of-care lateral flow assay.

Rugemalila J, Maro VP, Kapanda G, Ndaro AJ, Jarvis JN.

Trop Med Int Health. 2013 Sep;18(9):1075-1079. doi: 10.1111/tmi.12157.

7.

Implementation and Operational Research: Evaluation of a Public-Sector, Provider-Initiated Cryptococcal Antigen Screening and Treatment Program, Western Cape, South Africa.

Vallabhaneni S, Longley N, Smith M, Smith R, Osler M, Kelly N, Cross A, Boulle A, Meintjes G, Govender NP.

J Acquir Immune Defic Syndr. 2016 Jun 1;72(2):e37-e42. doi: 10.1097/QAI.0000000000000976.

8.

LATERAL FLOW ASSAY FOR CRYPTOCOCCAL ANTIGEN: AN IMPORTANT ADVANCE TO IMPROVE THE CONTINUUM OF HIV CARE AND REDUCE CRYPTOCOCCAL MENINGITIS-RELATED MORTALITY.

Vidal JE, Boulware DR.

Rev Inst Med Trop Sao Paulo. 2015 Sep;57 Suppl 19:38-45. doi: 10.1590/S0036-46652015000700008. Review.

9.

Evaluation of screening and treatment of cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa.

Govender NP, Roy M, Mendes JF, Zulu TG, Chiller TM, Karstaedt AS.

HIV Med. 2015 Sep;16(8):468-76. doi: 10.1111/hiv.12245. Epub 2015 Feb 17.

10.

Cryptococcal Antigen Screening in Patients Initiating ART in South Africa: A Prospective Cohort Study.

Longley N, Jarvis JN, Meintjes G, Boulle A, Cross A, Kelly N, Govender NP, Bekker LG, Wood R, Harrison TS.

Clin Infect Dis. 2016 Mar 1;62(5):581-587. doi: 10.1093/cid/civ936. Epub 2015 Nov 12.

11.

Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986-2012.

McKenney J, Bauman S, Neary B, Detels R, French A, Margolick J, Doherty B, Klausner JD.

Clin Infect Dis. 2015 Mar 15;60(6):959-65. doi: 10.1093/cid/ciu937. Epub 2014 Nov 24.

12.

Feasibility and Acceptability of Cryptococcal Antigen Screening and Prevalence of Cryptocococcemia in Patients Attending a Resource-Limited HIV/AIDS Clinic in Malawi.

Chipungu C, Veltman JA, Jansen P, Chiliko P, Lossa C, Namarika D, Benner B, Hoffman RM, Bristow CC, Klausner JD.

J Int Assoc Provid AIDS Care. 2015 Sep-Oct;14(5):387-90. doi: 10.1177/2325957415592475. Epub 2015 Jul 2.

PMID:
26139095
13.

Evaluation of fingerstick cryptococcal antigen lateral flow assay in HIV-infected persons: a diagnostic accuracy study.

Williams DA, Kiiza T, Kwizera R, Kiggundu R, Velamakanni S, Meya DB, Rhein J, Boulware DR.

Clin Infect Dis. 2015 Aug 1;61(3):464-7. doi: 10.1093/cid/civ263. Epub 2015 Apr 1.

14.

Prevalence of cryptococcal antigenemia and cost-effectiveness of a cryptococcal antigen screening program--Vietnam.

Smith RM, Nguyen TA, Ha HT, Thang PH, Thuy C, Lien TX, Bui HT, Le TH, Struminger B, McConnell MS, Fanfair RN, Park BJ, Harris JR.

PLoS One. 2013 Apr 23;8(4):e62213. doi: 10.1371/journal.pone.0062213. Print 2013.

15.

Cryptococcal antigen screening and preemptive therapy in patients initiating antiretroviral therapy in resource-limited settings: a proposed algorithm for clinical implementation.

Jarvis JN, Govender N, Chiller T, Park BJ, Longley N, Meintjes G, Bekker LG, Wood R, Lawn SD, Harrison TS.

J Int Assoc Physicians AIDS Care (Chic). 2012 Nov-Dec;11(6):374-9. doi: 10.1177/1545109712459077. Epub 2012 Sep 26.

PMID:
23015379
16.

Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings.

Meya DB, Manabe YC, Castelnuovo B, Cook BA, Elbireer AM, Kambugu A, Kamya MR, Bohjanen PR, Boulware DR.

Clin Infect Dis. 2010 Aug 15;51(4):448-55. doi: 10.1086/655143.

17.

Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast.

Boulware DR, Rolfes MA, Rajasingham R, von Hohenberg M, Qin Z, Taseera K, Schutz C, Kwizera R, Butler EK, Meintjes G, Muzoora C, Bischof JC, Meya DB.

Emerg Infect Dis. 2014 Jan;20(1):45-53. doi: 10.3201/eid2001.130906.

18.

Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in São Paulo, Brazil.

Vidal JE, Toniolo C, Paulino A, Colombo A, Dos Anjos Martins M, da Silva Meira C, Pereira-Chioccola VL, Figueiredo-Mello C, Barros T, Duarte J, Fonseca F, Alves Cunha M, Mendes C, Ribero T, Dos Santos Lazera M, Rajasingham R, Boulware DR.

Trop Med Int Health. 2016 Dec;21(12):1539-1544. doi: 10.1111/tmi.12790. Epub 2016 Oct 24.

PMID:
27699970
19.

Cryptococcal antigen screening and early antifungal treatment to prevent cryptococcal meningitis: a review of the literature.

Kaplan JE, Vallabhaneni S, Smith RM, Chideya-Chihota S, Chehab J, Park B.

J Acquir Immune Defic Syndr. 2015 Apr 15;68 Suppl 3:S331-9. doi: 10.1097/QAI.0000000000000484. Review.

PMID:
25768872
20.

Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings.

Lofgren S, Abassi M, Rhein J, Boulware DR.

Expert Rev Anti Infect Ther. 2017 Apr;15(4):331-340. doi: 10.1080/14787210.2017.1285697. Epub 2017 Feb 9. Review.

PMID:
28111998

Supplemental Content

Support Center